<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">463158059</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406164740.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170326e20070601xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10286-007-0407-2</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10286-007-0407-2</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="4">
   <subfield code="a">The effects of lorazepam on skin conductance responses to aversive stimuli in healthy subjects</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Martin Siepmann, Benjamin Heine, Andreas Kluge, Tjalf Ziemssen, Michael Mück-Weymann, Wilhelm Kirch]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: Autonomic responses to aversive stimuli are widely used to model anxiolytic drug effects in healthy humans. Benzodiazepine anxiolytics dose dependently attenuate autonomic responses to aversive stimuli by their anxiolytic as well as sedative action. The present study aimed to examine the effects of non-sedative doses of lorazepam on skin cutaneous responses to aversive stimuli and subjective mood. Methods: A randomized, double blind, cross over study of 12 healthy male volunteers aged 24years (23-32; median; range) was carried out. Subjects received single oral doses of 0.5 and 1.0mg lorazepam as well as placebo on three different occasions with at least 5days in-between. Skin conductance responses (SCRs) to unpleasant pictures and noises, pupillary unrest index as well as subjective levels of anxiety were measured repeatedly before and after drug administration. Results: SCRs were found significantly lower 2hours following ingestion of 0.5mg lorazepam as well as 1, 2 and 3hours after 1.0mg lorazepam were given as compared to baseline conditions. By contrast, administration of placebo did not influence SCRs to a significant extent. Both doses of lorazepam did not change pupillary unrest index nor subjective mood. Conclusions: Lorazepam may attenuate SCRs to aversive stimuli without affecting vigilance nor subjective mood. Attenuation of autonomic responses to aversive stimuli may not be specific for an anxiolytic effect.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer, 2007</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">skin-conductance responses</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">lorazepam</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">anxiolytic</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">sedative</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">subjective mood</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">healthy subjects</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Siepmann</subfield>
   <subfield code="D">Martin</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Heine</subfield>
   <subfield code="D">Benjamin</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kluge</subfield>
   <subfield code="D">Andreas</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ziemssen</subfield>
   <subfield code="D">Tjalf</subfield>
   <subfield code="u">Autonomic Laboratory, Department of Neurology, Medical Faculty, Technical University, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Mück-Weymann</subfield>
   <subfield code="D">Michael</subfield>
   <subfield code="u">Clinic for Psychotherapy and Psychosomatic Medicine, Medical Faculty, Technical University, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kirch</subfield>
   <subfield code="D">Wilhelm</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10286-007-0407-2</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10286-007-0407-2</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Siepmann</subfield>
   <subfield code="D">Martin</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Heine</subfield>
   <subfield code="D">Benjamin</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kluge</subfield>
   <subfield code="D">Andreas</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ziemssen</subfield>
   <subfield code="D">Tjalf</subfield>
   <subfield code="u">Autonomic Laboratory, Department of Neurology, Medical Faculty, Technical University, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Mück-Weymann</subfield>
   <subfield code="D">Michael</subfield>
   <subfield code="u">Clinic for Psychotherapy and Psychosomatic Medicine, Medical Faculty, Technical University, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kirch</subfield>
   <subfield code="D">Wilhelm</subfield>
   <subfield code="u">Institute of Clinical Pharmacology, Medical Faculty, Technical University, Fiedlerstraße 27, 01307, Dresden, Germany</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
